![Dmitri Lissin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dmitri Lissin
Teknisk/Vetenskaplig/F&U Direktör på
SCILEX HOLDING COMPANY
Profil
Dmitri V.
Lissin is currently Director & Chief Medical Officer at Semnur, Inc. since 2015.
He is Chief Medical Officer & Senior Vice President at Scilex, Inc. since 2019.
He holds the position of Chief Medical Officer & Senior Vice President at Scilex Holding Co. and Semnur Pharmaceuticals, Inc., both since 2015.
Formerly, Dr. Lissin was Vice President-Clinical Development at XenoPort, Inc. from 2011 to 2015.
Dr. Lissin earned a doctorate from Russian National Research Medical University.
Aktiva positioner av Dmitri Lissin
| Företag | Position | Start |
|---|---|---|
| SCILEX HOLDING COMPANY | Teknisk/Vetenskaplig/F&U Direktör | - |
Semnur, Inc.
 Semnur, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops and commercializes non-opioid pain therapies | Teknisk/Vetenskaplig/F&U Direktör | 2015-07-01 |
Scilex, Inc.
 Scilex, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pain management pharmaceutical products | Teknisk/Vetenskaplig/F&U Direktör | 2019-03-01 |
Tidigare kända positioner av Dmitri Lissin
| Företag | Position | Slut |
|---|---|---|
| XENOPORT, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2015-08-01 |
Dmitri Lissins utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
31
Första gradens relationer
5
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Semnur, Inc.
Semnur, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops and commercializes non-opioid pain therapies | Health Technology |
XenoPort, Inc.
 XenoPort, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing of pharmaceutical products for the potential treatment of neurological disorders | Health Technology |
Scilex, Inc.
Scilex, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pain management pharmaceutical products | Health Technology |
Russian National Research Medical University
 Russian National Research Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Scilex Holding Co.
 Scilex Holding Co. Pharmaceuticals: OtherHealth Technology Manufactures and wholesales non-opioid pain management products | Health Technology |
